A Broad Survey of Cathepsin K Immunoreactivity in Human Neoplasms
Year: 2013
Type: article
Study design: Observational Study
Abstract: Cathepsin K is consistently and diffusely expressed in alveolar soft part sarcoma (ASPS) and a subset of translocation renal cell carcinomas (RCCs). However, cathepsin K expression in human neoplasms has not been systematically analyzed. We constructed tissue microarrays (TMA) from a wide variety of human neoplasms, and performed cathepsin K immunohistochemistry (IHC). Only 2.7% of 1,140 carcinomas from various sites exhibited cathepsin K labeling, thus suggesting that among carcinomas, cathepsin K labeling is highly specific for translocation RCC. In contrast to carcinomas, cathepsin K labeling was relatively common (54.6%) in the 414 mesenchymal lesions studied, including granular cell tumor, melanoma, and histiocytic lesions, but not paraganglioma, all of which are in the morphologic differential diagnosis of ASPS. Cathepsin K IHC can be helpful in distinguishing ASPS and translocation RCC from some but not all of the lesions in their differential diagnosis.
Authors: Gang Zheng, Guido Martignoni, Cristina Antonescu, Elizabeth Montgomery, Charles Eberhart, George Netto, Janis Taube, William Westra, Jonathan I. Epstein, Tamara Lotan, Anirban Maitra, Edward Gabrielson, Michael Torbenson, Christine Iacobuzio-Donahue, Angelo Demarzo, Ie Ming Shih, Peter Illei, T.C. Wu, Pedram Argani
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Award: G1165598027
OpenAlex ID: W2127102417
